MicroRNAs as Therapeutic Targets and Colorectal Cancer Therapeutics (Q38291096)

1 September 2017

1 reference

title

MicroRNAs as Therapeutic Targets and Colorectal Cancer Therapeutics (English)

1 reference

1 September 2017

1 reference

1 reference

1 reference

Hirofumi Yamamoto

1

1 reference

1 September 2017

Masaki Mori

series ordinal

2

1 reference

1 September 2017

language of work or name

English

0 references

publication date

1 January 2016

1 reference

Advances in Experimental Medicine and Biology

1 September 2017

published in

1 reference

1 September 2017

volume

937

1 reference

1 September 2017

page(s)

239-247

1 reference

Mir-34: a new weapon against cancer?

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

The effective dispersion of nanovectors within the tumor microvasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

A genetic model for colorectal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

MicroRNAs in the p53 network: micromanagement of tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

Circulating miR-34a levels are reduced in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

SNAIL and miR-34a feed-forward regulation of ZNF281/ZBP99 promotes epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

Dividing cellular asymmetry: asymmetric cell division and its implications for stem cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

Asymmetry-defective oligodendrocyte progenitors are glioma precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

The cancer stem cell: premises, promises and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

Role of anti-oncomirs miR-143 and -145 in human colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

The role of microRNAs in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

Loss of miR-101 expression promotes Wnt/β-catenin signalling pathway activation and malignancy in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

MicroRNA-21: A novel therapeutic target in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

MicroRNA-21 promotes tumour malignancy via increased nuclear translocation of β-catenin and predicts poor outcome in APC-mutated but not in APC-wild-type colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

Anti-miR-21 Suppresses Hepatocellular Carcinoma Growth via Broad Transcriptional Network Deregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

Hsa-miR-19a is associated with lymph metastasis and mediates the TNF-α induced epithelial-to-mesenchymal transition in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

EGFR antagonists in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

PEAK: a randomized, multicenter phase II study of panitumumab plus modified fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) or bevacizumab plus mFOLFOX6 in patients with previously untreated, unresectable, wild-type KRAS exon 2 metastatic color

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

RAS is regulated by the let-7 microRNA family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

High let-7a microRNA levels in KRAS-mutated colorectal carcinomas may rescue anti-EGFR therapy effects in patients with chemotherapy-refractory metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

MicroRNA-30b functions as a tumour suppressor in human colorectal cancer by targeting KRAS, PIK3CD and BCL2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

miR-612 negatively regulates colorectal cancer growth and metastasis by targeting AKT2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

Concurrent Targeting of KRAS and AKT by MiR-4689 Is a Novel Treatment Against Mutant KRAS Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

The Regulatory Role of MicroRNAs in EMT and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

miR-1269 promotes metastasis and forms a positive feedback loop with TGF-β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFβR2) in colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

MicroRNA silencing for cancer therapy targeted to the tumour microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

Plasma miR-21: a potential diagnostic marker of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42059-2_13

10.1007/978-3-319-42059-2_13

31 March 2020

Identifiers

DOI

1 reference

1 September 2017

1 reference